Full text
1/2021
vol. 8
Review paper
Comparison of two currently available anti-COVID-19 vaccines
- Zakład Immunopatologii, Wydział Lekarski, Oddział Nauk Biomedycznych, Uniwersytet Medyczny w Łodzi
Alergologia Polska – Polish Journal of Allergology 2021; 8, 1: 19–20
Data publikacji online: 2021/01/12
Article file
- Use of mRNA COVID-19 Vaccines: Interim Clinical Considerations. Advisory Committee on Immunization Practices, December 19, 2020.
- Moderna COVID-19 Vaccine. Advisory Committee on Immunization Practices, December 19, 2020.
- Pfizer BioNTech COVID-19 Vaccine. Advisory Committee on Immunization Practices, December 11, 2020.
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383: 2603-2615.
- Castells MC, Phillips EJ. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med 2020; doi: 10.1056/NEJMra2035343 [In press].
- ChPL Comirnaty.
- ChPL Moderna.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
